Verona Pharma plc
VRNADelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657312
Verona Pharma plc was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 243 institutions reported holding it in 13F filings for Q3 2025, worth $8.57B in total; superinvestors Duquesne Family Office and Soros Fund Management held it.
13F holders, Q4 2025
Institutional positions in Verona Pharma plc as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
VRNA is no longer listed, and 13F filings after Q3 2025 list far fewer holders. See Q3 2025
- Institutional holders
- 1
- −238 vs. Q3 2025
- Shares held
- 20.0K
- −80.1M (−100.0%) vs. Q3 2025
- Total value
- $359.0K
- −$8.55B (−100.0%) vs. Q3 2025
- New holders
- 0
- 0 more added
- Sold out
- 238
- 0 more reduced
4 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $359.0K |
| Q3 2025 | 243 | $8.57B |
| Q2 2025 | 292 | $7.18B |
| Q1 2025 | 258 | $4.58B |
| Q4 2024 | 191 | $3.19B |
| Q3 2024 | 150 | $1.95B |
| Q2 2024 | 125 | $957.0M |
| Q1 2024 | 113 | $1.08B |
| Q4 2023 | 117 | $1.35B |
| Q3 2023 | 102 | $1.07B |
| Q2 2023 | 105 | $1.33B |
| Q1 2023 | 95 | $1.21B |
| Q4 2022 | 88 | $1.31B |
| Q3 2022 | 68 | $529.0M |
| Q2 2022 | 40 | $145.9M |
| Q1 2022 | 39 | $181.7M |
| Q4 2021 | 42 | $248.0M |
| Q3 2021 | 40 | $202.7M |
| Q2 2021 | 37 | $239.9M |
| Q1 2021 | 37 | $305.1M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Verona Pharma plc; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DekaBank Deutsche Girozentrale | 20,000 | $359.0K | 0.00% | 00.0% | Unchanged |
| Pentwater Capital Management LP | 0 | $0 | 0.00% | −5,300,000−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −4,283,462−100.0% | Sold out |
| HBK Investments L P | 0 | $0 | 0.00% | −4,263,576−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −3,826,710−100.0% | Sold out |
| FIL Ltd | 0 | $0 | 0.00% | −3,488,500−100.0% | Sold out |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −3,383,950−100.0% | Sold out |
| Davidson Kempner Capital Management LP | 0 | $0 | 0.00% | −3,271,623−100.0% | Sold out |
| Glazer Capital, LLC | 0 | $0 | 0.00% | −3,205,878−100.0% | Sold out |
| NEA Management Company, LLC | 0 | $0 | 0.00% | −2,252,994−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −1,935,278−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −1,863,426−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −1,796,738−100.0% | Sold out |
| Summit Partners Public Asset Management, LLC | 0 | $0 | 0.00% | −1,785,407−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −1,575,904−100.0% | Sold out |
| Whitebox Advisors LLC | 0 | $0 | 0.00% | −1,566,501−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −1,414,770−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −1,393,716−100.0% | Sold out |
| Vivo Capital, LLC | 0 | $0 | 0.00% | −1,393,432−100.0% | Sold out |
| Syquant Capital SAS | 0 | $0 | 0.00% | −1,208,312−100.0% | Sold out |
| Alpine Associates Management Inc. | 0 | $0 | 0.00% | −1,157,050−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −1,010,564−100.0% | Sold out |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 0 | $0 | 0.00% | −1,002,080−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −970,000−100.0% | Sold out |
| Omni Event Management Ltd | 0 | $0 | 0.00% | −962,341−100.0% | Sold out |
| Vivaldi Asset Management, LLC | 0 | $0 | 0.00% | −909,123−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −811,841−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −721,212−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −718,343−100.0% | Sold out |
| Eventide Asset Management, LLC | 0 | $0 | 0.00% | −680,929−100.0% | Sold out |
| TIG Advisors, LLC | 0 | $0 | 0.00% | −635,267−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −628,260−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −625,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −615,900−100.0% | Sold out |
| Aisling Capital Management LP | 0 | $0 | 0.00% | −615,352−100.0% | Sold out |
| Highland Capital Management Fund Advisors, L.P. | 0 | $0 | 0.00% | −584,601−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −524,088−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −517,012−100.0% | Sold out |
| CNH Partners LLC | 0 | $0 | 0.00% | −513,778−100.0% | Sold out |
| Twin Securities, Inc. | 0 | $0 | 0.00% | −501,113−100.0% | Sold out |
| Highbridge Capital Management LLC | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Westchester Capital Management, LLC | 0 | $0 | 0.00% | −483,655−100.0% | Sold out |
| Oddo BHF Asset Management SAS | 0 | $0 | 0.00% | −467,471−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −461,869−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −455,334−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −438,062−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −415,732−100.0% | Sold out |
| Absolute Gestao de Investimentos Ltda. | 0 | $0 | 0.00% | −413,432−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Artia Global Partners LP | 0 | $0 | 0.00% | −379,004−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −375,000−100.0% | Sold out |
| Gabelli Funds LLC | 0 | $0 | 0.00% | −372,744−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −337,445−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −337,143−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −317,587−100.0% | Sold out |
| Capula Management Ltd | 0 | $0 | 0.00% | −295,665−100.0% | Sold out |
| Water Island Capital LLC | 0 | $0 | 0.00% | −290,182−100.0% | Sold out |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 0 | $0 | 0.00% | −285,185−100.0% | Sold out |
| Birnam Oak Advisors, LP | 0 | $0 | 0.00% | −277,604−100.0% | Sold out |
| Gabelli & Co Investment Advisers, Inc. | 0 | $0 | 0.00% | −265,266−100.0% | Sold out |
| Grantham, Mayo, Van Otterloo & Co. LLC | 0 | $0 | 0.00% | −264,115−100.0% | Sold out |
| Readystate Asset Management LP | 0 | $0 | 0.00% | −262,265−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −245,000−100.0% | Sold out |
| Taconic Capital Advisors LP | 0 | $0 | 0.00% | −232,930−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −231,508−100.0% | Sold out |
| P Schoenfeld Asset Management LP | 0 | $0 | 0.00% | −221,200−100.0% | Sold out |
| Cinctive Capital Management LP | 0 | $0 | 0.00% | −221,054−100.0% | Sold out |
| Harvest Management LLC | 0 | $0 | 0.00% | −207,000−100.0% | Sold out |
| Hennion & Walsh Asset Management, Inc. | 0 | $0 | 0.00% | −185,819−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −185,303−100.0% | Sold out |
| Loomis Sayles & Co L P | 0 | $0 | 0.00% | −177,769−100.0% | Sold out |
| Atika Capital Management LLC | 0 | $0 | 0.00% | −176,000−100.0% | Sold out |
| Slotnik Capital, LLC | 0 | $0 | 0.00% | −170,834−100.0% | Sold out |
| Gardner Lewis Asset Management L P | 0 | $0 | 0.00% | −165,592−100.0% | Sold out |
| Gamco Investors, Inc. Et Al | 0 | $0 | 0.00% | −163,800−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −160,565−100.0% | Sold out |
| Colony Group, LLC | 0 | $0 | 0.00% | −150,005−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −148,120−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −147,768−100.0% | Sold out |
| Angelo Gordon & Co., L.P. | 0 | $0 | 0.00% | −145,000−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −143,200−100.0% | Sold out |
| Credit Industriel Et Commercial | 0 | $0 | 0.00% | −137,552−100.0% | Sold out |
| Nwi Management LP | 0 | $0 | 0.00% | −135,000−100.0% | Sold out |
| Chicago Capital Management, LLC | 0 | $0 | 0.00% | −129,600−100.0% | Sold out |
| Groupe la Francaise | 0 | $0 | 0.00% | −127,309−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −127,177−100.0% | Sold out |
| Clearbridge Investments, LLC | 0 | $0 | 0.00% | −119,217−100.0% | Sold out |
| Quantessence Capital LLC | 0 | $0 | 0.00% | −110,237−100.0% | Sold out |
| Melqart Asset Management (UK) Ltd | 0 | $0 | 0.00% | −107,991−100.0% | Sold out |
| Rosalind Advisors, Inc. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Trium Capital LLP | 0 | $0 | 0.00% | −99,837−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −99,300−100.0% | Sold out |
| Yakira Capital Management, Inc. | 0 | $0 | 0.00% | −98,500−100.0% | Sold out |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −98,378−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −95,539−100.0% | Sold out |
| Tokio Marine Asset Management Co Ltd | 0 | $0 | 0.00% | −95,000−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −92,298−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −89,887−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −81,654−100.0% | Sold out |